Global Human Micobiome Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Publisher Name :
Date: 09-Jun-2018
No. of pages: 152

The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).

These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.

An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.

Scope of the Report:

This report studies the Human Micobiome market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Human Micobiome market by product type and applications/end industries.

The research usually can last 8-10 years, so scale production will occur in 2018. Before then, the Human Micobiome companies have to continue deficit.

At present, global investment concentrates in US and Europe, US takes 70% market share and Europe takes 25% market share. There are a few manufacturers in the world and the market concentration is high. The top5 (investment in Human Micobiome) companies are Vedanta, Seres Therapeutics, Second Genome, Rebiocix, ActoGeniX. The five companies occupy about 70% of the market share.

The global Human Micobiome market is valued at 170 million USD in 2017 and is expected to reach 610 million USD by the end of 2023, growing at a CAGR of 23.9% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Human Micobiome.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

- - Vedanta

- - Seres Therapeutics

- - Second Genome

- - Rebiotix

- - ActoGeniX

- - Enterome BioScience

- - AvidBiotics

- - 4D Pharma Research Ltd

- - Enterologics

- - Metabogen

- - Metabiomics

- - Ritter Pharmaceuticals

- - Osel

- - Symberix

- - Miomics

- - Symbiotix Biotherapies

- - MicroBiome Therapeutics LLC

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- - Gastrointestinal Tract Human Micobiome

- - Urogenital Tract Human Micobiome

- - Other

Market Segment by Applications, can be divided into

- - Treatment

- - Diagnosis

Global Human Micobiome Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Table of Contents

1 Human Micobiome Market Overview
1.1 Product Overview and Scope of Human Micobiome
1.2 Classification of Human Micobiome by Types
1.2.1 Global Human Micobiome Revenue Comparison by Types (2017-2023)
1.2.2 Global Human Micobiome Revenue Market Share by Types in 2017
1.2.3 Gastrointestinal Tract Human Micobiome
1.2.4 Urogenital Tract Human Micobiome
1.2.5 Other
1.3 Global Human Micobiome Market by Application
1.3.1 Global Human Micobiome Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Treatment
1.3.3 Diagnosis
1.4 Global Human Micobiome Market by Regions
1.4.1 Global Human Micobiome Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Human Micobiome Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Human Micobiome Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Human Micobiome Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Human Micobiome Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Human Micobiome Status and Prospect (2013-2023)
1.5 Global Market Size of Human Micobiome (2013-2023)
2 Manufacturers Profiles
2.1 Vedanta
2.1.1 Business Overview
2.1.2 Human Micobiome Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Vedanta Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
2.2 Seres Therapeutics
2.2.1 Business Overview
2.2.2 Human Micobiome Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Seres Therapeutics Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
2.3 Second Genome
2.3.1 Business Overview
2.3.2 Human Micobiome Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Second Genome Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
2.4 Rebiotix
2.4.1 Business Overview
2.4.2 Human Micobiome Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Rebiotix Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
2.5 ActoGeniX
2.5.1 Business Overview
2.5.2 Human Micobiome Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 ActoGeniX Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
2.6 Enterome BioScience
2.6.1 Business Overview
2.6.2 Human Micobiome Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Enterome BioScience Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
2.7 AvidBiotics
2.7.1 Business Overview
2.7.2 Human Micobiome Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 AvidBiotics Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
2.8 4D Pharma Research Ltd
2.8.1 Business Overview
2.8.2 Human Micobiome Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 4D Pharma Research Ltd Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
2.9 Enterologics
2.9.1 Business Overview
2.9.2 Human Micobiome Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Enterologics Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
2.10 Metabogen
2.10.1 Business Overview
2.10.2 Human Micobiome Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Metabogen Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
2.11 Metabiomics
2.11.1 Business Overview
2.11.2 Human Micobiome Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Metabiomics Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
2.12 Ritter Pharmaceuticals
2.12.1 Business Overview
2.12.2 Human Micobiome Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Ritter Pharmaceuticals Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
2.13 Osel
2.13.1 Business Overview
2.13.2 Human Micobiome Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Osel Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
2.14 Symberix
2.14.1 Business Overview
2.14.2 Human Micobiome Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Symberix Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
2.15 Miomics
2.15.1 Business Overview
2.15.2 Human Micobiome Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Miomics Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
2.16 Symbiotix Biotherapies
2.16.1 Business Overview
2.16.2 Human Micobiome Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Symbiotix Biotherapies Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
2.17 MicroBiome Therapeutics LLC
2.17.1 Business Overview
2.17.2 Human Micobiome Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 MicroBiome Therapeutics LLC Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
3 Global Human Micobiome Market Competition, by Players
3.1 Global Human Micobiome Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Human Micobiome Players Market Share
3.2.2 Top 10 Human Micobiome Players Market Share
3.3 Market Competition Trend
4 Global Human Micobiome Market Size by Regions
4.1 Global Human Micobiome Revenue and Market Share by Regions
4.2 North America Human Micobiome Revenue and Growth Rate (2013-2018)
4.3 Europe Human Micobiome Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Human Micobiome Revenue and Growth Rate (2013-2018)
4.5 South America Human Micobiome Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Human Micobiome Revenue and Growth Rate (2013-2018)
5 North America Human Micobiome Revenue by Countries
5.1 North America Human Micobiome Revenue by Countries (2013-2018)
5.2 USA Human Micobiome Revenue and Growth Rate (2013-2018)
5.3 Canada Human Micobiome Revenue and Growth Rate (2013-2018)
5.4 Mexico Human Micobiome Revenue and Growth Rate (2013-2018)
6 Europe Human Micobiome Revenue by Countries
6.1 Europe Human Micobiome Revenue by Countries (2013-2018)
6.2 Germany Human Micobiome Revenue and Growth Rate (2013-2018)
6.3 UK Human Micobiome Revenue and Growth Rate (2013-2018)
6.4 France Human Micobiome Revenue and Growth Rate (2013-2018)
6.5 Russia Human Micobiome Revenue and Growth Rate (2013-2018)
6.6 Italy Human Micobiome Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Human Micobiome Revenue by Countries
7.1 Asia-Pacific Human Micobiome Revenue by Countries (2013-2018)
7.2 China Human Micobiome Revenue and Growth Rate (2013-2018)
7.3 Japan Human Micobiome Revenue and Growth Rate (2013-2018)
7.4 Korea Human Micobiome Revenue and Growth Rate (2013-2018)
7.5 India Human Micobiome Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Human Micobiome Revenue and Growth Rate (2013-2018)
8 South America Human Micobiome Revenue by Countries
8.1 South America Human Micobiome Revenue by Countries (2013-2018)
8.2 Brazil Human Micobiome Revenue and Growth Rate (2013-2018)
8.3 Argentina Human Micobiome Revenue and Growth Rate (2013-2018)
8.4 Colombia Human Micobiome Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Human Micobiome by Countries
9.1 Middle East and Africa Human Micobiome Revenue by Countries (2013-2018)
9.2 Saudi Arabia Human Micobiome Revenue and Growth Rate (2013-2018)
9.3 UAE Human Micobiome Revenue and Growth Rate (2013-2018)
9.4 Egypt Human Micobiome Revenue and Growth Rate (2013-2018)
9.5 Nigeria Human Micobiome Revenue and Growth Rate (2013-2018)
9.6 South Africa Human Micobiome Revenue and Growth Rate (2013-2018)
10 Global Human Micobiome Market Segment by Type
10.1 Global Human Micobiome Revenue and Market Share by Type (2013-2018)
10.2 Global Human Micobiome Market Forecast by Type (2018-2023)
10.3 Gastrointestinal Tract Human Micobiome Revenue Growth Rate (2013-2023)
10.4 Urogenital Tract Human Micobiome Revenue Growth Rate (2013-2023)
10.5 Other Revenue Growth Rate (2013-2023)
11 Global Human Micobiome Market Segment by Application
11.1 Global Human Micobiome Revenue Market Share by Application (2013-2018)
11.2 Human Micobiome Market Forecast by Application (2018-2023)
11.3 Treatment Revenue Growth (2013-2018)
11.4 Diagnosis Revenue Growth (2013-2018)
12 Global Human Micobiome Market Size Forecast (2018-2023)
12.1 Global Human Micobiome Market Size Forecast (2018-2023)
12.2 Global Human Micobiome Market Forecast by Regions (2018-2023)
12.3 North America Human Micobiome Revenue Market Forecast (2018-2023)
12.4 Europe Human Micobiome Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Human Micobiome Revenue Market Forecast (2018-2023)
12.6 South America Human Micobiome Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Human Micobiome Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source


List of Tables and Figures

Figure Human Micobiome Picture
Table Product Specifications of Human Micobiome
Table Global Human Micobiome and Revenue (Million USD) Market Split by Product Type
Figure Global Human Micobiome Revenue Market Share by Types in 2017
Figure Gastrointestinal Tract Human Micobiome Picture
Figure Urogenital Tract Human Micobiome Picture
Figure Other Picture
Table Global Human Micobiome Revenue (Million USD) by Application (2013-2023)
Figure Human Micobiome Revenue Market Share by Applications in 2017
Figure Treatment Picture
Figure Diagnosis Picture
Table Global Market Human Micobiome Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Human Micobiome Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Human Micobiome Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Human Micobiome Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Human Micobiome Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Human Micobiome Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Human Micobiome Revenue (Million USD) and Growth Rate (2013-2023)
Table Vedanta Basic Information, Manufacturing Base and Competitors
Table Vedanta Human Micobiome Type and Applications
Table Vedanta Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
Table Seres Therapeutics Basic Information, Manufacturing Base and Competitors
Table Seres Therapeutics Human Micobiome Type and Applications
Table Seres Therapeutics Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
Table Second Genome Basic Information, Manufacturing Base and Competitors
Table Second Genome Human Micobiome Type and Applications
Table Second Genome Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
Table Rebiotix Basic Information, Manufacturing Base and Competitors
Table Rebiotix Human Micobiome Type and Applications
Table Rebiotix Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
Table ActoGeniX Basic Information, Manufacturing Base and Competitors
Table ActoGeniX Human Micobiome Type and Applications
Table ActoGeniX Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
Table Enterome BioScience Basic Information, Manufacturing Base and Competitors
Table Enterome BioScience Human Micobiome Type and Applications
Table Enterome BioScience Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
Table AvidBiotics Basic Information, Manufacturing Base and Competitors
Table AvidBiotics Human Micobiome Type and Applications
Table AvidBiotics Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
Table 4D Pharma Research Ltd Basic Information, Manufacturing Base and Competitors
Table 4D Pharma Research Ltd Human Micobiome Type and Applications
Table 4D Pharma Research Ltd Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
Table Enterologics Basic Information, Manufacturing Base and Competitors
Table Enterologics Human Micobiome Type and Applications
Table Enterologics Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
Table Metabogen Basic Information, Manufacturing Base and Competitors
Table Metabogen Human Micobiome Type and Applications
Table Metabogen Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
Table Metabiomics Basic Information, Manufacturing Base and Competitors
Table Metabiomics Human Micobiome Type and Applications
Table Metabiomics Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
Table Ritter Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ritter Pharmaceuticals Human Micobiome Type and Applications
Table Ritter Pharmaceuticals Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
Table Osel Basic Information, Manufacturing Base and Competitors
Table Osel Human Micobiome Type and Applications
Table Osel Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
Table Symberix Basic Information, Manufacturing Base and Competitors
Table Symberix Human Micobiome Type and Applications
Table Symberix Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
Table Miomics Basic Information, Manufacturing Base and Competitors
Table Miomics Human Micobiome Type and Applications
Table Miomics Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
Table Symbiotix Biotherapies Basic Information, Manufacturing Base and Competitors
Table Symbiotix Biotherapies Human Micobiome Type and Applications
Table Symbiotix Biotherapies Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
Table MicroBiome Therapeutics LLC Basic Information, Manufacturing Base and Competitors
Table MicroBiome Therapeutics LLC Human Micobiome Type and Applications
Table MicroBiome Therapeutics LLC Human Micobiome Revenue, Gross Margin and Market Share (2016-2017)
Table Global Human Micobiome Revenue (Million USD) by Players (2013-2018)
Table Global Human Micobiome Revenue Share by Players (2013-2018)
Figure Global Human Micobiome Revenue Share by Players in 2016
Figure Global Human Micobiome Revenue Share by Players in 2017
Figure Global Top 5 Players Human Micobiome Revenue Market Share in 2017
Figure Global Top 10 Players Human Micobiome Revenue Market Share in 2017
Figure Global Human Micobiome Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Human Micobiome Revenue (Million USD) by Regions (2013-2018)
Table Global Human Micobiome Revenue Market Share by Regions (2013-2018)
Figure Global Human Micobiome Revenue Market Share by Regions (2013-2018)
Figure Global Human Micobiome Revenue Market Share by Regions in 2017
Figure North America Human Micobiome Revenue and Growth Rate (2013-2018)
Figure Europe Human Micobiome Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Human Micobiome Revenue and Growth Rate (2013-2018)
Figure South America Human Micobiome Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Human Micobiome Revenue and Growth Rate (2013-2018)
Table North America Human Micobiome Revenue by Countries (2013-2018)
Table North America Human Micobiome Revenue Market Share by Countries (2013-2018)
Figure North America Human Micobiome Revenue Market Share by Countries (2013-2018)
Figure North America Human Micobiome Revenue Market Share by Countries in 2017
Figure USA Human Micobiome Revenue and Growth Rate (2013-2018)
Figure Canada Human Micobiome Revenue and Growth Rate (2013-2018)
Figure Mexico Human Micobiome Revenue and Growth Rate (2013-2018)
Table Europe Human Micobiome Revenue (Million USD) by Countries (2013-2018)
Figure Europe Human Micobiome Revenue Market Share by Countries (2013-2018)
Figure Europe Human Micobiome Revenue Market Share by Countries in 2017
Figure Germany Human Micobiome Revenue and Growth Rate (2013-2018)
Figure UK Human Micobiome Revenue and Growth Rate (2013-2018)
Figure France Human Micobiome Revenue and Growth Rate (2013-2018)
Figure Russia Human Micobiome Revenue and Growth Rate (2013-2018)
Figure Italy Human Micobiome Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Human Micobiome Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Human Micobiome Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Human Micobiome Revenue Market Share by Countries in 2017
Figure China Human Micobiome Revenue and Growth Rate (2013-2018)
Figure Japan Human Micobiome Revenue and Growth Rate (2013-2018)
Figure Korea Human Micobiome Revenue and Growth Rate (2013-2018)
Figure India Human Micobiome Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Human Micobiome Revenue and Growth Rate (2013-2018)
Table South America Human Micobiome Revenue by Countries (2013-2018)
Table South America Human Micobiome Revenue Market Share by Countries (2013-2018)
Figure South America Human Micobiome Revenue Market Share by Countries (2013-2018)
Figure South America Human Micobiome Revenue Market Share by Countries in 2017
Figure Brazil Human Micobiome Revenue and Growth Rate (2013-2018)
Figure Argentina Human Micobiome Revenue and Growth Rate (2013-2018)
Figure Colombia Human Micobiome Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Human Micobiome Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Human Micobiome Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Human Micobiome Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Human Micobiome Revenue Market Share by Countries in 2017
Figure Saudi Arabia Human Micobiome Revenue and Growth Rate (2013-2018)
Figure UAE Human Micobiome Revenue and Growth Rate (2013-2018)
Figure Egypt Human Micobiome Revenue and Growth Rate (2013-2018)
Figure Nigeria Human Micobiome Revenue and Growth Rate (2013-2018)
Figure South Africa Human Micobiome Revenue and Growth Rate (2013-2018)
Table Global Human Micobiome Revenue (Million USD) by Type (2013-2018)
Table Global Human Micobiome Revenue Share by Type (2013-2018)
Figure Global Human Micobiome Revenue Share by Type (2013-2018)
Figure Global Human Micobiome Revenue Share by Type in 2017
Table Global Human Micobiome Revenue Forecast by Type (2018-2023)
Figure Global Human Micobiome Market Share Forecast by Type (2018-2023)
Figure Global Gastrointestinal Tract Human Micobiome Revenue Growth Rate (2013-2018)
Figure Global Urogenital Tract Human Micobiome Revenue Growth Rate (2013-2018)
Figure Global Other Revenue Growth Rate (2013-2018)
Table Global Human Micobiome Revenue by Application (2013-2018)
Table Global Human Micobiome Revenue Share by Application (2013-2018)
Figure Global Human Micobiome Revenue Share by Application (2013-2018)
Figure Global Human Micobiome Revenue Share by Application in 2017
Table Global Human Micobiome Revenue Forecast by Application (2018-2023)
Figure Global Human Micobiome Market Share Forecast by Application (2018-2023)
Figure Global Treatment Revenue Growth Rate (2013-2018)
Figure Global Diagnosis Revenue Growth Rate (2013-2018)
Figure Global Human Micobiome Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Human Micobiome Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Human Micobiome Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Human Micobiome Revenue Market Forecast (2018-2023)
Figure Europe Human Micobiome Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Human Micobiome Revenue Market Forecast (2018-2023)
Figure South America Human Micobiome Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Human Micobiome Revenue Market Forecast (2018-2023)
  • Global DNA Forensic Market Research Report 2018
    Published: 19-Jun-2018        Price: US 2900 Onwards        Pages: 91
    This report studies the global DNA Forensic market status and forecast, categorizes the global DNA Forensic market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China and other regions (India, Southeast Asia, Central & South America, and Middle East & Africa). DNA forensics is a branch of forensic science that focuses on the use of genetic material in criminal investigation to an......
  • Global Somatostatin Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Jun-2018        Price: US 3480 Onwards        Pages: 150
    Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin. Scope of the Report: This report focuses on the Somatostatin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East an......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Somatostatin Market 2018, Forecast to 2023
    Published: 19-Jun-2018        Price: US 4880 Onwards        Pages: 151
    Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin. Scope of the Report: This report focuses on the Somatostatin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East an......
  • 2015-2023 World Biological Safety Testing Market Research Report by Product Type, End-User (Application) and Regions (Countries)
    Published: 16-Jun-2018        Price: US 2800 Onwards        Pages: 112
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. Market Segment as follows: By Region / Countries - North America (U.S., Canada, Mexico) - Europe (Germany, U.K., France, Italy, Russia, Spain etc) - South America (Brazil, Argentina etc) - Middle East & Afri......
  • Global Procalcitonin Antibody Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Jun-2018        Price: US 3480 Onwards        Pages: 152
    Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli.Procalcitonin Antibody refers to the specific protein which can qualitatively and quantit......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Procalcitonin Antibody Market 2018, Forecast to 2023
    Published: 15-Jun-2018        Price: US 4880 Onwards        Pages: 150
    Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli.Procalcitonin Antibody refers to the specific protein which can qualitatively and quantit......
  • Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Jun-2018        Price: US 3480 Onwards        Pages: 132
    Epidermal growth factor (EGF) is a growth factor that stimulates cell growth, proliferation, and differentiation by binding to its receptor EGFR. Human EGF is a 6045-Da protein with 53 amino acid residues and three intramolecular disulfide bonds EGF results in cellular proliferation, differentiation, and survival. EGF considerably increases skin cell regeneration. More precisely, they can directly communicate to the skin cells to produce more collagen and elastin, that's why most sk......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market 2018, Forecast to 2023
    Published: 15-Jun-2018        Price: US 4880 Onwards        Pages: 136
    Epidermal growth factor (EGF) is a growth factor that stimulates cell growth, proliferation, and differentiation by binding to its receptor EGFR. Human EGF is a 6045-Da protein with 53 amino acid residues and three intramolecular disulfide bonds EGF results in cellular proliferation, differentiation, and survival. EGF considerably increases skin cell regeneration. More precisely, they can directly communicate to the skin cells to produce more collagen and elastin, that's why most sk......
  • Transfer Membrane Market by Type (PVDF, Nitrocellulose, Nylon), Transfer Method (Tank, Semi-dry, Dry), Application (Western, Northern, Southern Blot, Protein Sequencing), End user (Academia, Diagnolab, Pharmaceutical Companies) - Global Forecast to 2023
    Published: 15-Jun-2018        Price: US 5650 Onwards        Pages: 124
    “The global transfer membrane market projected to grow at a CAGR of 1.5%.” The global transfer membrane market is projected to reach 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5%. Factors such as increasing financial support from public and private funding sources for life science research, high prevalence of target diseases across the globe, and increasing research and development expenditure by pharmaceutical and biotechnology ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs